Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 1985-1989

  Powles, Mary Ann ^a   Liberator, Paul ^a   Anderson, Jennifer ^a   Karkhanis, Yashwant ^a   Dropinski, James F ^a   Bouffard, F Aileen ^a   Balkovec, James M ^a   Fujioka, Hisashi ^b   Aikawa, Masamichi ^b   Mcfadden, Diane ^c   Schmatz, Dennis ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; PNEUMOCANDIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITE CONTROL; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031903649     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.1985     Document Type: Article

References (14)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of echinocandin antifungal MK-0991 (L-743,872) efficacy in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338.
2. Absar, N., H. Daneshvar, and G. Beall. 1994. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J. Allergy Clin. Immunol. 93:1001-1005.
3. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
4. Frenkel, J., J. Good, and J. Schultz. 1966. Latent pneumocystic infections in rats, relapse and chemotherapy. Lab. Invest. 15:1559-1577.
5. Gluckstein, D., and J. Ruskin. 1995. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin. Infect. Dis. 20:849-853.
6. Liberator, P. A., J. W. Anderson, M. Powles, L. A. Pittarelli, M. Worley, M. Becker-Hapak, D. C. Graves, and D. M. Schmatz. 1992. Comparative study of antipneumocystis agents in rats by using a Pneumocystis carinii-specific DNA probe to quantitate infection. J. Clin. Microbiol. 30:2968-2974.
7. Matsumoto, Y., S. Matsuda, and T. Tegoshi. 1989. Yeast glucan in the cyst wall of Pneumocytis carinii. J. Protozool. 36:21S-22S.
8. Nguyen, M., P. J. Weiss, and M. R. Wallace. 1995. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV infected patients. AIDS 9: 573-575.
9. 0 analog L-733,560. Antimi-crob. Agents Chemother. 38:2258-2265.
10. Palusci, V. J., A. Kaul, R. M. Lawrence, K. A. Haines, and P. L. Kwitten. 1996. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr. Infect. Dis. J. 15:456-460.
11. Powles M. A., D. C. McFadden, P. A. Liberator, J. W. Anderson, E. B. Vadas, D. Meisner, and D. M. Schmatz. 1994. Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats. Antimicrob. Agents Chemother. 38:1397-1401.
12. Schmatz, D. M., M. A. Powles, D. M. McFadden, K. Nollstadt, F. A. Bouffard, J. F. Dropinski, P. Liberator, and J. Anderson. 1995. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrob. Agents Chemother. 39:1320-1323.
13. Schmatz, D. M., M. A. Powles, D. C. McFadden, L. Pittarelli, J. Balkovec, M. Hammond, R. Zambias, P. Liberator, and J. Anderson. 1992. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats. Antimicrob. Agents Chemother. 36:1964-1970.
14. Schmatz, D. M., M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3, β-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87:5950-5954.